Approval · Notice of Compliance 24809 · 2020
OLMETEC PLUS: Notice of Compliance 24809
Issued December 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24809
- Date
- December 16, 2020
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OLMETEC PLUS | Not yet assigned | — |
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- OLMESARTAN MEDOXOMIL 20 MG per TAB
- OLMESARTAN MEDOXOMIL 40 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB